| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.01 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.01 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.65 | 0.02 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |